News
Sensorion Will Present at The H.C. Wainwright Gene Therapy and Gene Editing Virtual Conference on March 30th, 2022
Regulatory News:
Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and
DGAP-News: freenet AG: freenet AG confirms 2021 preliminary results and guidance for 2022
DGAP-News: Steinhoff International Holdings N.V. : Annual General Meeting
Apple Hospitality REIT Announces Dates for First Quarter 2022 Earnings Release and Conference Call
Apple Hospitality REIT, Inc. (NYSE: APLE) (the “Company” or “Apple Hospitality”) today announced that it plans to report first quarter 2022 financial results after the market closes on Thursday
Tufin Technical Support Awarded a Bronze Stevie Award
Tufin® (NYSE: TUFN), a company pioneering a policy-centric approach to security and IT operations, today announced that Tufin Technical Support won a Bronze Stevie® Award in the Customer Service
Updated 2-THE-TOP Data Suggest Improvements in Progression-Free Survival, Overall Survival Compared to Matched-Control Patients from EF-14 Trial
Novocure (NASDAQ: NVCR) today announced that Dr. David Tran, Chief of the Division of Neuro-Oncology at the McKnight Brain Institute at the University of Florida, will present updated results from
ABIONYX Announces Positive Clinical Findings for CER-001 in Treating COVID-19, Published in Biomedecines, Demonstrating That CER-001 Limits Inflammation Effects
Regulatory News:
ABIONYX Pharma (FR0012616852 - ABNX - PEA PME eligible) (Paris:ABNX), a new generation biotech company dedicated to the discovery and development of innovative therapies for
ABB Plans to Launch New Share Buyback of up to $3 Billion Following Completion of 2021-2022 Program
ABB has completed its share buyback program that was launched in April 2021 as part of the company’s commitment to return to shareholders cash proceeds from the Power Grids divestment of $7.8
India's GTPL Hathway Selects Verimatrix To Secure Sweeping Android TV Rollout
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that GTPL Hathway Limited
2021 Annual Report Publication
DGAP-Adhoc: ElringKlinger AG: Contract of CEO Dr. Stefan Wolf extended ahead of schedule, guidance for 2022 suspended
DGAP-News: Contract of CEO Dr. Stefan Wolf extended ahead of schedule, guidance for 2022 suspended
DGAP-Adhoc: KUKA Aktiengesellschaft: Guangdong Midea Electric Co., Ltd. specifies transfer request of 23 November 2021
LivaNova to Announce First-Quarter 2022 Results
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first-quarter 2022 results on Wednesday, May 4, 2022 at 1 p.m
Philip Morris International Inc. (PMI) Announces Concrete Steps to Scale Down Operations in the Russian Federation and Its Intention to Exit the Market
Regulatory News:
Further to its announcement released on March 9, 2022, Philip Morris International Inc. (NYSE: PM) today announces the concrete steps it has taken to suspend planned investments
State Street Collateral+ Platform Now Live with Pirum’s CollateralConnect Service
State Street Corporation (NYSE:STT) announced today the integration of its Collateral+ platform with Pirum’s CollateralConnect service to support mutual clients with collateral management and
Nordea Bank Abp: Nordea's Board of Directors has decided on payment of ordinary dividend in its statutory meeting
Farmers National Banc Corp. and Emclaire Financial Corp. Announce Merger
Farmers National Banc Corp. (“Farmers”) (NASDAQ: FMNB), the holding company for The Farmers National Bank of Canfield (“Farmers Bank”), and Emclaire Financial Corp. (“Emclaire”) (NASDAQ: EMCF), the
Lineage to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC on March 28, 2022
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M
PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study
Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”)
Biomind Labs to Commence Commercial Clinical Trial on Its Proprietary Mescaline Candidate BMND06
Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company developing the next generation of pharmaceuticals to treat patients suffering from
Viad Corp to Expand Pursuit’s Glacier Park Collection With Acquisition
Viad Corp (NYSE:VVI), a leading global provider of extraordinary experiences, including hospitality and leisure activities, experiential marketing, and live events, today announced that it has
Graham Corporation Announces Changes to Board of Directors
Graham Corporation (NYSE: GHM), a global business that designs, manufactures and sells critical equipment for the defense/space, energy/new energy and chemical/petrochemical industries, today